SOLARA Solara Active Pharma Sciences Ltd Earnings Reports Announcement 2025 - Q4 FY25 Results Solara Active Pharma Sciences Limited reported its Q4 FY25 performance with revenues of INR 2,790 million and an EBITDA of INR 510 million, reflecting a significant increase in gross margin and EBITDA despite a challenging year..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Solara Active Pharma Sciences Ltd